|
CDK5RAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.312400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.121300E-03 |
| Normal-vs-Stage2 |
5.035200E-03 |
| Normal-vs-Stage3 |
2.511800E-01 |
| Normal-vs-Stage4 |
7.878600E-01 |
| Stage1-vs-Stage2 |
8.932000E-01 |
| Stage1-vs-Stage3 |
3.915800E-01 |
| Stage1-vs-Stage4 |
1.129220E-01 |
| Stage2-vs-Stage3 |
4.469800E-01 |
| Stage2-vs-Stage4 |
2.628600E-01 |
| Stage3-vs-Stage4 |
5.969400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.240000E-02 |
| Normal-vs-AfricanAmerican |
1.460300E-03 |
| Normal-vs-Asian |
1.535680E-02 |
| Caucasian-vs-AfricanAmerican |
1.017590E-01 |
| Caucasian-vs-Asian |
1.898970E-01 |
| AfricanAmerican-vs-Asian |
2.650200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.172120E-02 |
| Normal-vs-Female |
1.783380E-01 |
| Male-vs-Female |
1.306010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.650000E-02 |
| Normal-vs-Extreme_Weight |
4.746200E-02 |
| Normal-vs-Obese |
1.810620E-01 |
| Normal-vs-Extreme_Obese |
2.442300E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.041400E-01 |
| Normal_Weight-vs-Obese |
4.780400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.563800E-02 |
| Extreme_Weight-vs-Obese |
5.332800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.787800E-02 |
| Obese-vs-Extreme_Obese |
8.257900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.964000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.871200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.76210000000832E-05 |
| Normal-vs-Age(81-100Yrs) |
1.705240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.122200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.096600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.833400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.826650E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.518000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.382800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.833600E-02 |
| Normal-VS-Type2 PRCC |
3.061800E-02 |
| Normal-VS-KIRP CIMP |
3.540200E-01 |
| Normal-VS-Unclassified PRCC |
5.916300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.555400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.296600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.516800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.054200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.404600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.164200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.037900E-03 |
| Normal-vs-N1 |
5.246600E-01 |
| Normal-vs-N2 |
5.903800E-01 |
| N0-vs-N1 |
8.556300E-02 |
| N0-vs-N2 |
4.641000E-01 |
| N1-vs-N2 |
8.849800E-01 |
|
|
